MBIO - Latest News

Mustang Bio, Inc. (MBIO), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $4.8M. Beta to the broader market is 2.11.

The article list below shows the most recent MBIO headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent MBIO Headlines

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Harnesses Key AI, Voice Analysis to Offer Impairment Solution

globenewswire.com - May 14, 2026

Disseminated on behalf of  MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)  and may include paid advertising.

IBN Announces Latest Episode of The TechMediaWire Podcast featuring Justin Hanka, CEO of MindBio Therapeutics Corp.

globenewswire.com - May 12, 2026

This news release has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising This news release has been dissemina

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Leveraging AI, Voice Analysis to Develop Intoxication Detection

globenewswire.com - May 12, 2026

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

MindBio Announces Closing of Private Placement

thenewswire.com - Apr 1, 2026

Vancouver, British Columbia – April 1, 2026 – TheNewswire -  MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF)  (the “ Company

MindBio Announces Upsize to Private Placement up to $1.5 Million

thenewswire.com - Mar 19, 2026

Vancouver, British Columbia –  TheNewswire - March 19, 2026  –  MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF),  (the “ Comp

How News Affects MBIO Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MBIO's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked MBIO news questions

What is the latest MBIO news headline?
The most recent MBIO headline (May 14, 2026) is "MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Harnesses Key AI, Voice Analysis to Offer Impairment Solution". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the MBIO news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What MBIO news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual MBIO options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.